Evaluating BioStrength Training for Muscle Strength in Adults
A Comparative Study of Training Effectiveness: Technogyms Biostrength Devices Vs. Conventional Strength Training Devices: a Randomized Controlled Trial
This study is testing if using advanced BioStrength machines can help adults build muscle strength better than regular strength training equipment over 12 weeks.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 42 (estimated) |
| Ages | 30 Years to 65 Years |
| Sex | All |
| Sponsor | University of Graz Academic / other |
| Locations | 1 site (Leibnitz, Styria, Styria) |
| Trial ID | NCT06727695 on ClinicalTrials.gov |
What this trial studies
This study evaluates the effectiveness of Technogyms BioStrength equipment compared to traditional strength training equipment over a 12-week period. Participants will be randomly assigned to either the BioStrength group, which uses advanced machines providing real-time feedback, or the traditional training group. Key measurements will include maximum strength tests, handgrip strength, and body composition assessments. The study aims to determine if BioStrength machines lead to superior improvements in muscle strength and body composition.
Who should consider this trial
Good fit: Ideal candidates are healthy adults aged 30 to 65 with less than 6 months of prior strength training experience.
Not a fit: Patients with significant medical conditions, such as a history of coronary heart disease or stroke, may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could provide a more effective training method for improving muscle strength and body composition in adults.
How similar studies have performed: Other studies have shown positive outcomes with innovative strength training technologies, suggesting potential for success in this approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * • Age between 30 and 65 years * Healthy individuals without significant medical conditions * Less than 6 months of prior strength training experience * Willing and able to participate in a 12-week training program * Capable of performing strength training exercises such as leg press and chest press * Able to provide written informed consent Exclusion Criteria: * • History of coronary heart disease * History of stroke * Need for changes in antihypertensive treatment within 3 months prior to study start * Arthritis * Pregnancy or less than three months postpartum * Pain and movement restrictions * Use of medications that affect muscle strength or performance (e.g., anabolic steroids, beta-2 agonists, glucocorticoids, statins, benzodiazepines, ACE inhibitors, angiotensin-II receptor blockers, diuretics) * Any medical condition preventing participation in planned endurance and strength training
Where this trial is running
Leibnitz, Styria, Styria
- CF Leibnitz — Leibnitz, Styria, Styria, Austria (Recruiting)
Study contacts
- Principal investigator: Martin Atia — University of Graz
- Study coordinator: Martin Atia
- Email: m.atia@edu.uni-graz.at
- Phone: +436642524153
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.